Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

Ex-cath lab tech indicted in Hep-C outbreak

A former cath lab medical technician dubbed the “serial infector” has been indicted by a federal grand jury in connection with a hepatitis C outbreak in New Hampshire and several other states.

Thumbnail

Study: Warfarin’s benefits extend to six months after valve surgery

Patients who undergo bioprosthetic aortic valve replacement surgery likely will benefit from anticoagulation therapy that is extended three months beyond the duration recommended in guidelines, researchers report in the Nov. 28 issue of the Journal of the American Medical Association. The results offer compelling evidence to change practice, according to the researchers and authors of a companion editorial.

Florida hospitals pay $10M to settle CV suit

Morton Plant Mease Health Care and its affiliated hospitals, which serve two Tampa Bay counties in Florida, have agreed to pay more than $10 million to the federal government to resolve allegations that they improperly billed for interventional cardiac and vascular procedures.

Simple model predicts risk of stent thrombosis, but is it necessary?

It is possible to predict the risk that a patient will develop stent thrombosis after PCI for treatment of acute coronary syndrome using an assessment tool that considers several readily available variables, according to a study published in the November issue of the Journal of the American College of Cardiology: Cardiovascular Interventions.

Abiomed investors file civil suit, seeking jury trial

A class action complaint was filed on Nov. 16 in the United States District Court for the District of Massachusetts by Karse Simon and Arlene Simon, on behalf of themselves and persons or entities that purchased or acquired Abiomed's securities between Aug. 5, 2011, and Oct. 31, 2012, against Abiomed, Michael R. Minogue, Abiomed's chairman, president and CEO, and Robert L. Bowen, Abiomed's chief financial officer.

Unemployment associated with higher risk of MI

People older than 51 years of age who lose their jobs have a significantly higher risk of suffering acute MI (AMI) after that event, according to a study published online Nov. 19 in Annals of Internal Medicine.

Societies advise tailored approach to stable ischemic heart disease

Proper treatment of stable ischemic heart disease requires an individualized approach developed in consultation with the patient, but is often best managed through appropriate lifestyle changes and drug therapy, according to Guidelines for the Diagnosis and Management of Patients with Stable Ischemic Heart Disease, released Nov. 19 by the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and endorsed by several other societies.

Edwards wins THV patent duel with Medtronic

A federal appeals court upheld a jury decision that Medtronic CoreValve infringed the Andersen transcatheter heart valve (THV) patent owned by Edwards Lifesciences.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.